A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model-Reference-Cited by-同舟云学术

A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model

Author:

Blommestein Hedwig M.¹²,Verelst Silvia G. R.³,de Groot Saskia¹,Huijgens Peter C.²⁴,Sonneveld Pieter³,Uyl-de Groot Carin A.¹²

Affiliation:

1. Department of Health Policy & Management/institute for Medical Technology Assessment; Erasmus University; Rotterdam The Netherlands

2. Comprehensive Cancer Organisation; Utrecht The Netherlands

3. Erasmus Medical Center Rotterdam; Rotterdam The Netherlands

4. VU Medical Center Amsterdam; Amsterdam The Netherlands

Funder

Netherlands Organisation for Health Research and Development

Hoffman-La Roche

Janssen Research and Development

Celgene

Sanofi

GlaxoSmithKline

Bristol-Myers Squibb

Bayer

MSD

Mundipharma

Novartis

Publisher

Wiley

Subject

Hematology,General Medicine

Link

Reference40 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

5. Prognostic factors in multiple myeloma;Kyle;Stem Cells,1995

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献